Apax Sues Endo Over $1.2B Qualitest Deal
Endo Pharmaceuticals was hit Monday with a suit from Apax Partners, which claims Endo is requesting coverage for "phantom" third-party claims under a 2010 $1.2 billion agreement to buy generic drug...To view the full article, register now.
Already a subscriber? Click here to view full article